Lineage Cell Therapeutics, Inc (LCTX) insider trading
Every open-market stock purchase and sale by Lineage Cell Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- Last insider buy: Brian M Culley (CEO), $24.4K, 7 months ago.
Last 12 months: insiders bought $24.4K (1 buy) and sold $0 (0 sales). Last close $0.98 on Oct 22, 2026.
Recent LCTX insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jul 1, 2026 | Michael H. Mulroy (Insider) | Bought (not open market) | — |
| Jul 1, 2026 | Anula Jayasuriya (Insider) | Bought (not open market) | — |
| Jul 1, 2026 | Deborah J Andrews (Insider) | Bought (not open market) | — |
| Jul 1, 2026 | Angus C. Russell (Insider) | Bought (not open market) | — |
| Jul 1, 2026 | Dipti Amin (Insider) | Bought (not open market) | — |
| Jul 1, 2026 | Neal C Bradsher (10% owner) | Bought (not open market) | — |
| Mar 12, 2026 | Brian M Culley (CEO) | Bought | $24.4K |
| Mar 5, 2026 | Jill Ann Howe (CFO) | Bought (not open market) | — |
| Mar 5, 2026 | Brian M Culley (CEO) | Bought (not open market) | — |
| Mar 5, 2026 | George A. Samuel III (General Counsel) | Bought (not open market) | — |
| Feb 11, 2026 | Brian M Culley (CEO) | Sold (not open market) | $23.2K |
| Feb 11, 2026 | George A. Samuel III (General Counsel) | Sold (not open market) | $4.5K |
| Feb 11, 2026 | Brian M Culley (CEO) | Bought (not open market) | — |
| Feb 11, 2026 | George A. Samuel III (General Counsel) | Bought (not open market) | — |
| Dec 19, 2025 | Brian M Culley (CEO) | Sold (not open market) | $561 |
| Dec 19, 2025 | George A. Samuel III (General Counsel) | Sold (not open market) | $109 |
| Dec 19, 2025 | Brian M Culley (CEO) | Bought (not open market) | — |
| Dec 19, 2025 | George A. Samuel III (General Counsel) | Bought (not open market) | — |
Who's trading LCTX
- Deborah J Andrews, Insider: other filings, last Jul 1, 2026
- Dipti Amin, Insider: other filings, last Jul 1, 2026
- Angus C. Russell, Insider: other filings, last Jul 1, 2026
- Michael H. Mulroy, Insider: other filings, last Jul 1, 2026
- Anula Jayasuriya, Insider: other filings, last Jul 1, 2026
- Neal C Bradsher, 10% owner: other filings, last Jul 1, 2026
- Brian M Culley, CEO: bought $24.4K (1 buy), last Mar 12, 2026
- Jill Ann Howe, CFO: other filings, last Mar 5, 2026
- George A. Samuel III, General Counsel: other filings, last Mar 5, 2026
Get free alerts when an insider at Lineage Cell Therapeutics, Inc files a new trade →